The potent histone deacetylase inhibitor vorinostat, in combination with melphalan, markedly enhances the anti-myeloma effects of chemotherapy in vitro and in vivo
Year: 2008
Type: article
Source: Cancer Research
Authors: Richard A. Campbell, Eric Sanchez, Jeffrey A. Steinberg, Michael Share, Mingjie Li, Haiming Chen, Benjamin Bonavida, James R. Berenson
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2978102712
